MRTX1133 is undoubtedly an extremely potent and selective KRASG12D inhibitor. It optimally fills the swap II pocket and extends three substituents to favorably communicate with the protein. The K A further possible advantage of combining KRAS inhibitors and checkpoint inhibitors is the fact